Quercetin as a Senolytic: Mechanisms, Dosing, and Clinical Evidence
Expert Summary
Quercetin's senolytic mechanism centers on BCL-2 inhibition in senescent cells — the same strategy employed by pharmaceutical senolytic drugs. The landmark Mayo Clinic pilot study (Xu et al., 2019) demonstrated that dasatinib + quercetin (D+Q) reduced senescent cell abundance in adipose tissue biopsies, circulating SASP factors, and improved physical function in idiopathic pulmonary fibrosis patients.
Key Facts
- BCL-2 inhibition: Quercetin inhibits BCL-2 and BCL-XL at IC50 values of ~12 μM and ~14 μM respectively — achievable at high-bioavailability supplement doses. Senescent cells rely on these proteins to resist apoptosis.
- D+Q pilot results (PMID: 30616998): 9 IPF patients received 3 days of dasatinib 100 mg + quercetin 1,000 mg. Post-treatment adipose biopsies showed 35% reduction in p16+p21 senescent cells. Plasma SASP factors (MMPs, IL-6, IL-8) decreased significantly.
- Standalone quercetin: Without dasatinib, quercetin at 500–1,000 mg/day shows measurable reductions in IL-6, TNF-α, and CRP in multiple RCTs (primarily in metabolic syndrome and cardiovascular disease populations).
- Bioavailability imperative: Standard quercetin bioavailability is <5%. At this absorption level, 1,000 mg delivers <50 mg to systemic circulation — below senolytic IC50. Phytosome form achieves 5–50x higher plasma levels, making it critical for senolytic applications.
- Cycling protocol: For senolytic use, quercetin is taken in 2-day burst doses (coinciding with dasatinib or during fisetin burst days). For anti-inflammatory benefits, lower continuous doses (200–300 mg/day) maintain relevant plasma levels.
- Synergy with fisetin: Quercetin + fisetin targets BCL-2 (quercetin primary) and BCL-W/BCL-XL (fisetin primary) simultaneously — broader senolytic coverage than either alone.
Recommended Products
Frequently Asked Questions
Can I use quercetin as a senolytic without dasatinib?
Yes. Quercetin alone (especially in phytosome form) has documented anti-senescence and SASP-reducing effects. The D+Q combination is more potent, but quercetin-only approaches (especially combined with fisetin) represent a reasonable natural alternative.
What is the senolytic dose of quercetin?
The D+Q protocol uses quercetin 1,000 mg/day for 2 days (with dasatinib 100 mg). For natural-only protocols, quercetin phytosome 500–1,000 mg/day is used on burst days, commonly combined with fisetin 500–1,000 mg.
How does quercetin affect the gut microbiome?
Quercetin is partially metabolized by gut bacteria into phenolic acids. This interaction modulates microbiome composition, generally increasing Akkermansia muciniphila and reducing pro-inflammatory taxa — a beneficial secondary effect.
Scientific References
- Xu M et al. Senolytics improve physical function and increase lifespan in old age. Nature Medicine. 2018. PMID: 29988130
- Chirumbolo S et al. Quercetin as a potential anti-allergic drug. Allergy, Asthma, and Clinical Immunology. 2010. PMID: 21867560